Susquehanna International Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q2 | – | Sell |
-21,561
| Closed | -$100K | – | 5314 |
|
2019
Q1 | $100K | Sell |
21,561
-14,786
| -41% | -$68.6K | ﹤0.01% | 2677 |
|
2018
Q4 | $127K | Buy |
+36,347
| New | +$127K | ﹤0.01% | 3123 |
|
2018
Q3 | – | Sell |
-59,757
| Closed | -$433K | – | 5316 |
|
2018
Q2 | $433K | Sell |
59,757
-42,712
| -42% | -$309K | ﹤0.01% | 2347 |
|
2018
Q1 | $619K | Sell |
102,469
-17,139
| -14% | -$104K | ﹤0.01% | 1912 |
|
2017
Q4 | $1.15M | Buy |
+119,608
| New | +$1.15M | ﹤0.01% | 1645 |
|
2017
Q3 | – | Sell |
-28,112
| Closed | -$356K | – | 4731 |
|
2017
Q2 | $356K | Buy |
+28,112
| New | +$356K | ﹤0.01% | 2635 |
|
2017
Q1 | – | Sell |
-84,523
| Closed | -$778K | – | 4919 |
|
2016
Q4 | $778K | Buy |
+84,523
| New | +$778K | ﹤0.01% | 2521 |
|
2016
Q3 | – | Sell |
-89,427
| Closed | -$1.16M | – | 4400 |
|
2016
Q2 | $1.16M | Buy |
89,427
+57,730
| +182% | +$747K | ﹤0.01% | 1475 |
|
2016
Q1 | $507K | Buy |
+31,697
| New | +$507K | ﹤0.01% | 2641 |
|
2015
Q4 | – | Sell |
-65,637
| Closed | -$1.87M | – | 4806 |
|
2015
Q3 | $1.87M | Buy |
65,637
+55,463
| +545% | +$1.58M | ﹤0.01% | 1717 |
|
2015
Q2 | $365K | Buy |
+10,174
| New | +$365K | ﹤0.01% | 3620 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 4702 |
|
2014
Q4 | – | Sell |
-30,086
| Closed | -$583K | – | 4736 |
|
2014
Q3 | $583K | Buy |
30,086
+16,200
| +117% | +$314K | ﹤0.01% | 2819 |
|
2014
Q2 | $217K | Buy |
+13,886
| New | +$217K | ﹤0.01% | 3802 |
|
2014
Q1 | – | Hold |
0
| – | – | – | 4236 |
|
2013
Q4 | – | Hold |
0
| – | – | – | 4328 |
|